Recent Finacing
Recent Raise
Nanotherapeutics provides advanced drug development, clinical-trial management, and in-house cGMP biologics manufacturing (including a 180,000 sq ft NANO-ADM facility), leveraging proprietary platforms for small molecules, proteins, vaccines, and injectables.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors